Positron Corp (POSCD) 0.6200 $POSCD
CereScan Partners with Denver Outlaws Professional Lacrosse Team
PRWeb - Wed Jul 08, 1:00AM CDT
A unique partnership between a professional Lacrosse team and an advanced neurodiagnostic brain imaging company promises to bring education on concussions and traumatic brain injuries to the forefront. CereScan is one of the country's leading providers of SPECT (Single Photon Emission Computed Tomography) and PET/CT (Positron Emission Tomography/Computed Tomography) brain imaging that provides functional information about how the brain is actually working. In the sports world, this is particularly important if a player has sustained one or several concussions. CereScan's imaging process accurately detects what areas of the brain are affected and identifies a clear diagnosis for the patient's condition.
North America Nuclear Imaging Market 2015 - Growth, Trends And Forecasts to 2019
M2 - Thu Jun 11, 11:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rhxbv7/north_america) has announced the addition of the "North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019)" report to their offering. The nuclear imaging market is estimated to grow to $15.5 million by 2020 at a CAGR of 12.08% Nuclear medicine is the use of radioisotopes for the diagnosis of diseases. The two major types of Nuclear imaging used commonly are PET and SPECT. Till recently, SPECT imaging was the mainstream modality for nuclear medicine applications like nuclear cardiology procedures. However, the trend is soon going to change because of global shortage of molybdenum-99 isotope which is in turn will lead to shortage of Technetium-99, which is the daughter product of molybdenum. Hence, PET imaging products which include hybrid PET-CT scanners hold a potential market size in coming years. The cost associated with PET-CT service can be as high as $275,000 per year. PET market is expected to witness more growth compared to SPECT imaging as it provides higher resolution images and the lack of availability of technetium-99m is propelling industry to look for alternative diagnostic procedures. Analyzing the application segment of SPECT and PET, PET is majorly being used in oncology because of good quality of imaging while SPECT is majorly used in cardiology segment accounting for almost 90% of the market share in cardiology. North America accounts for the highest share of the global nuclear medicine diagnostic market. The rise in disease incidence and the fast advancement of technology in countries such as USA and Canada are the market drivers. Market is segmented into two major segments SPECT (Technetium-99m (TC-99m), Thallium-201 (TL-201), Iodine (I-123) and others) and PET (Fluorine-18, Rubidium-82 (RB-82) and others). The Market is segmented based on application market into SPECT (cardiology, lymphoma, thyroid, neurology and others) and PET (oncology, cardiology, neurology and others),by geography market (USA, Canada and others).Major players in the market are Cardiarc Ltd., Digirad Corporation, Gamme Medica Inc., GE healthcare, Hologic Inc. etc. Drivers: - Major factors for the growth of the market are increasing use of SPECT and PET analysis in radiopharmaceuticals, increased awareness of people for radiopharmaceuticals, and ready availability of radiopharmaceuticals. Novel applications such as Alzheimer's and continually expanding oncology application segment also drive the market. Constraints: - The short half- life of radioisotopes, high capital investment, regulatory guidelines and reimbursement issues are the constraints in this market. Company Profiles - Agfa-Gevaert N.V. - Cardiarc Ltd - Digirad Corporation - Gamma Medica Inc - Ge Healthcare - Hologic Inc. - Medx Inc - Naviscan Inc - Positron Corporation - Segami Corporation - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/rh...th_america
HOLX: 38.71 (+0.75)
South America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019)
M2 - Fri May 29, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5j86f8/south_america) has announced the addition of the "South America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019)" report to their offering. The South American market for Nuclear Imaging is expected to grow at a healthy CAGR from 2014 to 2020. Till now, SPECT imaging was the mainstream modality for nuclear medicine applications like nuclear cardiology procedures. However, the trend is soon going to flip upside down because of shortage of molybdenum-99 isotope which is in turn will lead to shortage of Technetium-99, which is the daughter product of molybdenum. Hence, PET imaging products which includes hybrid PET-CT scanners holds a potential market size in coming years. The cost associated with PET-CT service contract is usually 105 of the system purchase price annually and can be as high as $275,000 per year. The emerging market trend is fusion of nuclear imaging with different diagnostic imaging products such as PET/CT, SPECT/CT, and MRI/PET. This provides full gamut of imaging scans through the same unit and at the same time. PET market is expected to witness more growth compared to SPECT imaging as it provides higher resolution images and the lack of availability of technetium-99m is propelling industry to look for alternative diagnostic procedures. Analyzing the application segment of SPECT and PET, PET is majorly being used in oncology because of good quality of imaging. While, SPECT is majorly used in cardiology segment accounting for almost 90% of the market share in cardiology. The South American Nuclear Imaging Market is segregated on the basis of: - Diagnostic Technologies (SPECT Radioisotopes [Technetium-99m (TC-99m), Thallium-201 (TL-201), Iodine (I-123) and Others] and PET Radioisotopes [Fluorine-18, Rubidium-82 (RB-82) and Others]) - Applications (SPECT [Cardiology, Lymphoma, Thyroid, Neurology and Others] and PET [Oncology, Cardiology, Neurology and Others]) - Geography (Brazil, Mexico, Argentina and Others). Key Topics Covered - Introduction - Executive Summary - Market Overview - Porters Five Force Analysis - Market Segmentation - Competitive Landscape - Company Profiles Companies Mentioned - Agfa-Gevaert - Cardiarc - Digirad - Gamma Medica - Ge Healthcare - Hologic - Medx - Naviscan - Positron - Segami - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/5j...th_america
HOLX: 38.71 (+0.75)
Asia Pacific Nuclear Imaging Market - Growth, Trends And Forecasts. 2015 Report
M2 - Fri May 29, 8:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rfd9v2/asia_pacific) has announced the addition of the "Asia Pacific Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019)" report to their offering. The Asia Pacific nuclear imaging market is the fastest growing market. Nuclear medicine is the use of radioisotopes for the diagnosis of diseases. The two major types of Nuclear imaging used commonly are PET and SPECT. Till recently, SPECT imaging was the mainstream modality for nuclear medicine applications like nuclear cardiology procedures. However, the trend is soon going to change because of global shortage of molybdenum-99 isotope which is in turn will lead to shortage of Technetium-99, which is the daughter product of molybdenum. Hence, PET imaging products which include hybrid PET-CT scanners hold a potential market size in coming years. The cost associated with PET-CT service can be as high as $275,000 per year. PET market is expected to witness more growth compared to SPECT imaging as it provides higher resolution images and the lack of availability of technetium-99m is propelling industry to look for alternative diagnostic procedures. Asia Pacific region has the highest populous countries like China and India, which in turn contribute to a large aging population. There is also higher disease incidence in this region increasing the demand for advanced technologies like nuclear imaging. There is a large investment on the healthcare setup and medical research making these facilities accessible. The per capita income is increasing in these countries making such technologies more affordable. Key Topics Covered - Introduction - Executive Summary - Market Overview - Market Segmentation - Porters Five Force Analysis - Competitive Landscape - Company profiles - List of Tables Companies Mentioned - Agfa-Gevaert - Cardiarc - Digirad - Gamma Medica - Ge Healthcare - Hologic - Medx - Naviscan - Positron - Segami - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/rf...ia_pacific
HOLX: 38.71 (+0.75)
Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies
M2 - Thu May 28, 8:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n382vn/cytogenetics) has announced the addition of Jain PharmaBiotech's new report "Cytogenetics - Technologies, Markets and Companies" to their offering. This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease. In the age of molecular biology, it is also referred to as molecular cytogenetics. The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH. Molecular cytogenetics includes application of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection. Bioinformatics is described briefly as it plays an important role in analyzing data from many of these technologies. FISH remains the single most important technology in cytogenetics. Several innovations are described of which the most important are single copy FISH, in vivo FISH (imaging of nucleic acids in living cells) and nanotechnology-based FISH. The unique character of peptide nucleic acid (PNA) allows these probes to hybridize to target nucleic acid molecules more rapidly and with higher affinity and specificity compared with DNA probes. PNA-FISH is more suited for rapid diagnosis of infections. RNA-FISH and locked nucleic acids (LNAs), are also described. Microarray/biochip-based technologies for cytogenetics promise to speed up detection of chromosome aberrations now examined by FISH. Other important genomic technologies are whole genome expression array and direct molecular analysis without amplification. Analysis of single-cell gene expression promises a more precise understanding of human disease pathogenesis and has important diagnostic applications. Optical Mapping can survey entire human genomes for insertions/deletions, which account for a significantly greater proportion of genetic variation between closely-related genomes as compared to single nucleotide polymorphisms (SNPs), and are a major cause of gene defects. Technologies encompassed within molecular imaging include optical imaging, magnetic resonance imaging (MRI) and nuclear medicine techniques. Positron emission tomography (PET) is the most sensitive and specific technique for imaging molecular pathways in vivo in humans. Cytogenetics can be refined by application of cytogenetics at single molecule level. Nanotechnology has facilitated the development of technology for single molecule imaging. Atomic force microscope (AFM) has become a well-established technique for imaging single biomolecules under physiological conditions. The scanning probe microscope (SPM) system is emerging as an increasingly important tool for non-intrusive interrogation of biomolecular systems in vitro and have been applied to improve FISH. Another example of application of nanobiotechnology is QD (quantum dot)-FISH probes, which can detect down to the single molecule level. The report includes summary profiles of 69 companies relevant to cytogenetics along with their 79 collaborations. Companies developing innovative technologies as well as those supplying equipment/services/reagents are identified.The report text is supplemented with 27 Tables and 9 figures. Selected 200 references are included in the bibliography. Key Topics Covered: Executive Summary 1. Introduction 2. Technologies used for cytogenetics 3. Fluorescent In Situ Hybridization 4. Genomic Technologies relevant to Cytogenetics 5. Molecular Imaging & Single Molecular Detection 6. Role of Nanobiotechnology in Cytogenetics 7. Biomarkers and Cytogenetics 8. Applications of Cytogenetics 9. Cancer Cytogenetics 10. Cytogenetics Markets 11. Companies 12. References For more information visit http://www.researchandmarkets.com/research/n3...togenetics Source: Jain PharmaBiotech
Oncology Institute at European Medical Center in Moscow Opens PET Diagnostics and High-accuracy Radiotherapy Departments
PR Newswire Europe - Thu May 28, 12:01AM CDT
MOSCOW, May 28, 2015 /PRNewswire/ --
Market Assessment of Respiratory Diagnostics in the United States and Europe 2015
M2 - Thu May 21, 5:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/78bc48/market_assessment) has announced the addition of the "Market Assessment of Respiratory Diagnostics in the United States and Europe" report to their offering. This research service provides an analysis of the respiratory imaging diagnostics market in the United States and Europe. The service provides detailed analysis of the current and forecasted number of procedures, market size, and revenue forecast in respiratory diagnostics such as computed tomography, magnetic resonance imaging, positron emission tomography, x-ray, and spirometry. Market participants and key opinion leaders in the United States and Europe were interviewed to obtain perceptions of trends and opportunities in the respiratory diagnostics market. The study period is from 2011 to 2018, with 2013 as the base year. A CT scan is recommended for smokers over the age of (approximately million of the total million smokers), and million CT scans have been performed on people under the age of in the United States. The United States is the dominant region, with million lung-specific CT scans carried out every year; however, radiation exposure is a significant drawback of CT. Magnetic resonance imaging (MRI): Across geographies, the role of MRI for lung disease imaging is limited. Longer procedural time and a lack of precision to image a moving organ such as the lungs hamper the use of this type of imaging. Positron emission tomography (PET): This procedure is considered an alternative option for staging lung cancer, and it reduces radiation exposure when compared to CT. However, the high cost of equipment and the average cost of each scan is significantly high, which limits adoption in European countries as healthcare services are heavily subsidized. Healthcare service providers embrace radiation dose reduction technologies, reconstruction software, limited scan time, precise imaging of moving organs, and cost-effective products. The increasing incidences of lung disease across geographies provide a potential opportunity for technologies that satisfy the unmet needs in the current imaging modalities. Key Topics Covered: 1. Market Assessment of Respiratory Diagnostics in the United States and Europe 2. Executive Summary 3. Market Overview - Medical Imaging Industry 4. Clinical Workflow of Major Lung Disease Diagnosis in the United States 5. Lung Disease Incidences and Prevalence - Lung Conditions Requiring Medical Imaging Scans 6. Overall Medical Imaging Procedures by Country 7. Imaging Scans Market Size 8. Lung Imaging Market Breakdown by Geography 9. X-ray and Spirometry Market in the United States For more information visit http://www.researchandmarkets.com/research/78...assessment
Radiopharmaceuticals Market 2015: - Global Strategic Business Report
M2 - Thu Apr 30, 5:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bld7rj/radiopharmaceutica) has announced the addition of the "Radiopharmaceuticals - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Segments: Diagnostic Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 57 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc (US) - Advanced Medical Isotope Corporation (US) - Alliance Medical (UK) - Alseres Pharmaceuticals, Inc (US) - Avid Radiopharmaceuticals (US) - Bayer HealthCare Medical Care (US) - Bracco Diagnostics, Inc. (US) - Cardinal Health, Inc (US) - GE Healthcare (UK) - Ion Beam Applications S.A (Belgium) - Immunomedics, Inc. (US) - Jubilant Pharma (India) - Lantheus Medical Imaging Inc (US) - Mallinckrodt Pharmaceuticals (Ireland) - Medi-Radiopharma Ltd (Hungary) - Nordion, Inc. (Canada) - Peregrine Pharmaceuticals, Inc. (US) - PETNET Solutions Inc (US) - Positron Corporation (US) - Singapore Radiopharmaceuticals Pte Ltd (Singapore) - Triad Isotopes, Inc. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET TRENDS & ISSUES 3. RADIO ISOTOPES MO-99/TC 99 SUPPLIES A REVIEW 4. THERAPEUTIC RADIOPHARMACEUTICAL PRODUCTS UNDER DEVELOPMENT 5. IMAGING AGENTS AN OVERVIEW 6. NUCLEAR MEDICINE AN OVERVIEW 7. PRODUCT OVERVIEW 8. PRODUCT INNOVATIONS/INTRODUCTIONS 9. RECENT INDUSTRY ACTIVITY 10. FOCUS ON SELECT PLAYERS 11. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 57 (including Divisions/Subsidiaries 64) - The United States (28) - Canada (2) - Japan (1) - Europe (22) - - France (2) - - Germany (3) - - The United Kingdom (3) - - Italy (2) - - Spain (1) - - Rest of Europe (11) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/bl...rmaceutica
IMMU: 4.20 (+0.24), ATNM: 2.41 (+0.18), CAH: 85.48 (+1.32)
Nuclear Imaging Equipment In South Korea Market Analysis Report 2020: Radiant Insights, Inc
M2 - Thu Apr 09, 4:16AM CDT
GlobalData's new report, "South Korea Nuclear Imaging Equipment Market Outlook to 2020", provides key market data on the South Korea Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems).
CereScan Partners with Denver Outlaws Professional Lacrosse Team
PRWeb - Wed Jul 08, 1:00AM CDT
A unique partnership between a professional Lacrosse team and an advanced neurodiagnostic brain imaging company promises to bring education on concussions and traumatic brain injuries to the forefront. CereScan is one of the country's leading providers of SPECT (Single Photon Emission Computed Tomography) and PET/CT (Positron Emission Tomography/Computed Tomography) brain imaging that provides functional information about how the brain is actually working. In the sports world, this is particularly important if a player has sustained one or several concussions. CereScan's imaging process accurately detects what areas of the brain are affected and identifies a clear diagnosis for the patient's condition.
North America Nuclear Imaging Market 2015 - Growth, Trends And Forecasts to 2019
M2 - Thu Jun 11, 11:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rhxbv7/north_america) has announced the addition of the "North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019)" report to their offering. The nuclear imaging market is estimated to grow to $15.5 million by 2020 at a CAGR of 12.08% Nuclear medicine is the use of radioisotopes for the diagnosis of diseases. The two major types of Nuclear imaging used commonly are PET and SPECT. Till recently, SPECT imaging was the mainstream modality for nuclear medicine applications like nuclear cardiology procedures. However, the trend is soon going to change because of global shortage of molybdenum-99 isotope which is in turn will lead to shortage of Technetium-99, which is the daughter product of molybdenum. Hence, PET imaging products which include hybrid PET-CT scanners hold a potential market size in coming years. The cost associated with PET-CT service can be as high as $275,000 per year. PET market is expected to witness more growth compared to SPECT imaging as it provides higher resolution images and the lack of availability of technetium-99m is propelling industry to look for alternative diagnostic procedures. Analyzing the application segment of SPECT and PET, PET is majorly being used in oncology because of good quality of imaging while SPECT is majorly used in cardiology segment accounting for almost 90% of the market share in cardiology. North America accounts for the highest share of the global nuclear medicine diagnostic market. The rise in disease incidence and the fast advancement of technology in countries such as USA and Canada are the market drivers. Market is segmented into two major segments SPECT (Technetium-99m (TC-99m), Thallium-201 (TL-201), Iodine (I-123) and others) and PET (Fluorine-18, Rubidium-82 (RB-82) and others). The Market is segmented based on application market into SPECT (cardiology, lymphoma, thyroid, neurology and others) and PET (oncology, cardiology, neurology and others),by geography market (USA, Canada and others).Major players in the market are Cardiarc Ltd., Digirad Corporation, Gamme Medica Inc., GE healthcare, Hologic Inc. etc. Drivers: - Major factors for the growth of the market are increasing use of SPECT and PET analysis in radiopharmaceuticals, increased awareness of people for radiopharmaceuticals, and ready availability of radiopharmaceuticals. Novel applications such as Alzheimer's and continually expanding oncology application segment also drive the market. Constraints: - The short half- life of radioisotopes, high capital investment, regulatory guidelines and reimbursement issues are the constraints in this market. Company Profiles - Agfa-Gevaert N.V. - Cardiarc Ltd - Digirad Corporation - Gamma Medica Inc - Ge Healthcare - Hologic Inc. - Medx Inc - Naviscan Inc - Positron Corporation - Segami Corporation - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/rh...th_america
HOLX: 38.71 (+0.75)
South America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019)
M2 - Fri May 29, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5j86f8/south_america) has announced the addition of the "South America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019)" report to their offering. The South American market for Nuclear Imaging is expected to grow at a healthy CAGR from 2014 to 2020. Till now, SPECT imaging was the mainstream modality for nuclear medicine applications like nuclear cardiology procedures. However, the trend is soon going to flip upside down because of shortage of molybdenum-99 isotope which is in turn will lead to shortage of Technetium-99, which is the daughter product of molybdenum. Hence, PET imaging products which includes hybrid PET-CT scanners holds a potential market size in coming years. The cost associated with PET-CT service contract is usually 105 of the system purchase price annually and can be as high as $275,000 per year. The emerging market trend is fusion of nuclear imaging with different diagnostic imaging products such as PET/CT, SPECT/CT, and MRI/PET. This provides full gamut of imaging scans through the same unit and at the same time. PET market is expected to witness more growth compared to SPECT imaging as it provides higher resolution images and the lack of availability of technetium-99m is propelling industry to look for alternative diagnostic procedures. Analyzing the application segment of SPECT and PET, PET is majorly being used in oncology because of good quality of imaging. While, SPECT is majorly used in cardiology segment accounting for almost 90% of the market share in cardiology. The South American Nuclear Imaging Market is segregated on the basis of: - Diagnostic Technologies (SPECT Radioisotopes [Technetium-99m (TC-99m), Thallium-201 (TL-201), Iodine (I-123) and Others] and PET Radioisotopes [Fluorine-18, Rubidium-82 (RB-82) and Others]) - Applications (SPECT [Cardiology, Lymphoma, Thyroid, Neurology and Others] and PET [Oncology, Cardiology, Neurology and Others]) - Geography (Brazil, Mexico, Argentina and Others). Key Topics Covered - Introduction - Executive Summary - Market Overview - Porters Five Force Analysis - Market Segmentation - Competitive Landscape - Company Profiles Companies Mentioned - Agfa-Gevaert - Cardiarc - Digirad - Gamma Medica - Ge Healthcare - Hologic - Medx - Naviscan - Positron - Segami - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/5j...th_america
HOLX: 38.71 (+0.75)
Asia Pacific Nuclear Imaging Market - Growth, Trends And Forecasts. 2015 Report
M2 - Fri May 29, 8:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rfd9v2/asia_pacific) has announced the addition of the "Asia Pacific Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019)" report to their offering. The Asia Pacific nuclear imaging market is the fastest growing market. Nuclear medicine is the use of radioisotopes for the diagnosis of diseases. The two major types of Nuclear imaging used commonly are PET and SPECT. Till recently, SPECT imaging was the mainstream modality for nuclear medicine applications like nuclear cardiology procedures. However, the trend is soon going to change because of global shortage of molybdenum-99 isotope which is in turn will lead to shortage of Technetium-99, which is the daughter product of molybdenum. Hence, PET imaging products which include hybrid PET-CT scanners hold a potential market size in coming years. The cost associated with PET-CT service can be as high as $275,000 per year. PET market is expected to witness more growth compared to SPECT imaging as it provides higher resolution images and the lack of availability of technetium-99m is propelling industry to look for alternative diagnostic procedures. Asia Pacific region has the highest populous countries like China and India, which in turn contribute to a large aging population. There is also higher disease incidence in this region increasing the demand for advanced technologies like nuclear imaging. There is a large investment on the healthcare setup and medical research making these facilities accessible. The per capita income is increasing in these countries making such technologies more affordable. Key Topics Covered - Introduction - Executive Summary - Market Overview - Market Segmentation - Porters Five Force Analysis - Competitive Landscape - Company profiles - List of Tables Companies Mentioned - Agfa-Gevaert - Cardiarc - Digirad - Gamma Medica - Ge Healthcare - Hologic - Medx - Naviscan - Positron - Segami - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/rf...ia_pacific
HOLX: 38.71 (+0.75)
Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies
M2 - Thu May 28, 8:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n382vn/cytogenetics) has announced the addition of Jain PharmaBiotech's new report "Cytogenetics - Technologies, Markets and Companies" to their offering. This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease. In the age of molecular biology, it is also referred to as molecular cytogenetics. The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH. Molecular cytogenetics includes application of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection. Bioinformatics is described briefly as it plays an important role in analyzing data from many of these technologies. FISH remains the single most important technology in cytogenetics. Several innovations are described of which the most important are single copy FISH, in vivo FISH (imaging of nucleic acids in living cells) and nanotechnology-based FISH. The unique character of peptide nucleic acid (PNA) allows these probes to hybridize to target nucleic acid molecules more rapidly and with higher affinity and specificity compared with DNA probes. PNA-FISH is more suited for rapid diagnosis of infections. RNA-FISH and locked nucleic acids (LNAs), are also described. Microarray/biochip-based technologies for cytogenetics promise to speed up detection of chromosome aberrations now examined by FISH. Other important genomic technologies are whole genome expression array and direct molecular analysis without amplification. Analysis of single-cell gene expression promises a more precise understanding of human disease pathogenesis and has important diagnostic applications. Optical Mapping can survey entire human genomes for insertions/deletions, which account for a significantly greater proportion of genetic variation between closely-related genomes as compared to single nucleotide polymorphisms (SNPs), and are a major cause of gene defects. Technologies encompassed within molecular imaging include optical imaging, magnetic resonance imaging (MRI) and nuclear medicine techniques. Positron emission tomography (PET) is the most sensitive and specific technique for imaging molecular pathways in vivo in humans. Cytogenetics can be refined by application of cytogenetics at single molecule level. Nanotechnology has facilitated the development of technology for single molecule imaging. Atomic force microscope (AFM) has become a well-established technique for imaging single biomolecules under physiological conditions. The scanning probe microscope (SPM) system is emerging as an increasingly important tool for non-intrusive interrogation of biomolecular systems in vitro and have been applied to improve FISH. Another example of application of nanobiotechnology is QD (quantum dot)-FISH probes, which can detect down to the single molecule level. The report includes summary profiles of 69 companies relevant to cytogenetics along with their 79 collaborations. Companies developing innovative technologies as well as those supplying equipment/services/reagents are identified.The report text is supplemented with 27 Tables and 9 figures. Selected 200 references are included in the bibliography. Key Topics Covered: Executive Summary 1. Introduction 2. Technologies used for cytogenetics 3. Fluorescent In Situ Hybridization 4. Genomic Technologies relevant to Cytogenetics 5. Molecular Imaging & Single Molecular Detection 6. Role of Nanobiotechnology in Cytogenetics 7. Biomarkers and Cytogenetics 8. Applications of Cytogenetics 9. Cancer Cytogenetics 10. Cytogenetics Markets 11. Companies 12. References For more information visit http://www.researchandmarkets.com/research/n3...togenetics Source: Jain PharmaBiotech
Oncology Institute at European Medical Center in Moscow Opens PET Diagnostics and High-accuracy Radiotherapy Departments
PR Newswire Europe - Thu May 28, 12:01AM CDT
MOSCOW, May 28, 2015 /PRNewswire/ --
Market Assessment of Respiratory Diagnostics in the United States and Europe 2015
M2 - Thu May 21, 5:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/78bc48/market_assessment) has announced the addition of the "Market Assessment of Respiratory Diagnostics in the United States and Europe" report to their offering. This research service provides an analysis of the respiratory imaging diagnostics market in the United States and Europe. The service provides detailed analysis of the current and forecasted number of procedures, market size, and revenue forecast in respiratory diagnostics such as computed tomography, magnetic resonance imaging, positron emission tomography, x-ray, and spirometry. Market participants and key opinion leaders in the United States and Europe were interviewed to obtain perceptions of trends and opportunities in the respiratory diagnostics market. The study period is from 2011 to 2018, with 2013 as the base year. A CT scan is recommended for smokers over the age of (approximately million of the total million smokers), and million CT scans have been performed on people under the age of in the United States. The United States is the dominant region, with million lung-specific CT scans carried out every year; however, radiation exposure is a significant drawback of CT. Magnetic resonance imaging (MRI): Across geographies, the role of MRI for lung disease imaging is limited. Longer procedural time and a lack of precision to image a moving organ such as the lungs hamper the use of this type of imaging. Positron emission tomography (PET): This procedure is considered an alternative option for staging lung cancer, and it reduces radiation exposure when compared to CT. However, the high cost of equipment and the average cost of each scan is significantly high, which limits adoption in European countries as healthcare services are heavily subsidized. Healthcare service providers embrace radiation dose reduction technologies, reconstruction software, limited scan time, precise imaging of moving organs, and cost-effective products. The increasing incidences of lung disease across geographies provide a potential opportunity for technologies that satisfy the unmet needs in the current imaging modalities. Key Topics Covered: 1. Market Assessment of Respiratory Diagnostics in the United States and Europe 2. Executive Summary 3. Market Overview - Medical Imaging Industry 4. Clinical Workflow of Major Lung Disease Diagnosis in the United States 5. Lung Disease Incidences and Prevalence - Lung Conditions Requiring Medical Imaging Scans 6. Overall Medical Imaging Procedures by Country 7. Imaging Scans Market Size 8. Lung Imaging Market Breakdown by Geography 9. X-ray and Spirometry Market in the United States For more information visit http://www.researchandmarkets.com/research/78...assessment
Radiopharmaceuticals Market 2015: - Global Strategic Business Report
M2 - Thu Apr 30, 5:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bld7rj/radiopharmaceutica) has announced the addition of the "Radiopharmaceuticals - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Segments: Diagnostic Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 57 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc (US) - Advanced Medical Isotope Corporation (US) - Alliance Medical (UK) - Alseres Pharmaceuticals, Inc (US) - Avid Radiopharmaceuticals (US) - Bayer HealthCare Medical Care (US) - Bracco Diagnostics, Inc. (US) - Cardinal Health, Inc (US) - GE Healthcare (UK) - Ion Beam Applications S.A (Belgium) - Immunomedics, Inc. (US) - Jubilant Pharma (India) - Lantheus Medical Imaging Inc (US) - Mallinckrodt Pharmaceuticals (Ireland) - Medi-Radiopharma Ltd (Hungary) - Nordion, Inc. (Canada) - Peregrine Pharmaceuticals, Inc. (US) - PETNET Solutions Inc (US) - Positron Corporation (US) - Singapore Radiopharmaceuticals Pte Ltd (Singapore) - Triad Isotopes, Inc. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET TRENDS & ISSUES 3. RADIO ISOTOPES MO-99/TC 99 SUPPLIES A REVIEW 4. THERAPEUTIC RADIOPHARMACEUTICAL PRODUCTS UNDER DEVELOPMENT 5. IMAGING AGENTS AN OVERVIEW 6. NUCLEAR MEDICINE AN OVERVIEW 7. PRODUCT OVERVIEW 8. PRODUCT INNOVATIONS/INTRODUCTIONS 9. RECENT INDUSTRY ACTIVITY 10. FOCUS ON SELECT PLAYERS 11. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 57 (including Divisions/Subsidiaries 64) - The United States (28) - Canada (2) - Japan (1) - Europe (22) - - France (2) - - Germany (3) - - The United Kingdom (3) - - Italy (2) - - Spain (1) - - Rest of Europe (11) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/bl...rmaceutica
IMMU: 4.20 (+0.24), ATNM: 2.41 (+0.18), CAH: 85.48 (+1.32)
Nuclear Imaging Equipment In South Korea Market Analysis Report 2020: Radiant Insights, Inc
M2 - Thu Apr 09, 4:16AM CDT
GlobalData's new report, "South Korea Nuclear Imaging Equipment Market Outlook to 2020", provides key market data on the South Korea Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems).
